Celgene chief Alles discusses deal to acquire Impact Biomedicines, strategy for 2018

The full interview with Celgene's Mark Alles at the 2018 J.P. Morgan Health in San Francisco.
04:35
Mon, Jan 8 201812:29 PM EST